{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:04:15Z","timestamp":1791331455766,"version":"4.3.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science Bulletin"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.scib.2020.12.005","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T02:01:37Z","timestamp":1607479297000},"page":"925-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2"],"prefix":"10.1016","volume":"66","author":[{"given":"Chenjian","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scib.2020.12.005_b0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11684-020-0767-8","article-title":"Coronavirus disease 2019 (COVID-19): a clinical update","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.scib.2020.12.005_b0010","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S2213-2600(20)30161-2","article-title":"Intensive care management of coronavirus disease 2019 (COVID-19): Challenges and recommendations","volume":"8","author":"Phua","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.scib.2020.12.005_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RDRP): A molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.scib.2020.12.005_b0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.scib.2020.12.005_b0025","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe COVID-19","volume":"382","author":"Grein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2020.12.005_b0030","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.scib.2020.12.005_b0035","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19 - preliminary report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.scib.2020.12.005_b0040","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.2174\/0929867327666200416131117","article-title":"SARS-CoV-2: recent reports on antiviral therapies based on lopinavir\/ritonavir, darunavir\/umifenovir, hydroxychloroquine, remdesivir, favipiravir and other drugs for the treatment of the new coronavirus","volume":"27","author":"Costanzo","year":"2020","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.scib.2020.12.005_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.scib.2020.12.005_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.scib.2020.12.005_b0055","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"105949","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.scib.2020.12.005_b0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","article-title":"A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19","volume":"57","author":"Cortegiani","year":"2020","journal-title":"J Crit Care"},{"key":"10.1016\/j.scib.2020.12.005_b0065","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.medj.2020.06.001","article-title":"Outcomes of hydroxychloroquine usage in United States veterans hospitalized with COVID-19","volume":"1","author":"Magagnoli","year":"2020","journal-title":"Med"},{"key":"10.1016\/j.scib.2020.12.005_b0070","doi-asserted-by":"crossref","unstructured":"Suranagi UD, Rehan HS, Goyal N. Hydroxychloroquine for the management of COVID-19: hope or hype? A systematic review of the current evidence. medRxiv, 2020. https:\/\/doi.org\/10.1101\/2020.04.16.20068205.","DOI":"10.1101\/2020.04.16.20068205"},{"key":"10.1016\/j.scib.2020.12.005_b0075","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4049\/jimmunol.2000583","article-title":"A potently neutralizing antibody protects mice against SARS-CoV-2 infection","volume":"205","author":"Alsoussi","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.scib.2020.12.005_b0080","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.scib.2020.12.005_b0085","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"Shi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.scib.2020.12.005_b0090","first-page":"111","article-title":"Isolation of a 2019 novel coronavirus strain from a coronavirus disease 2019 patient in Shanghai","volume":"15","author":"Zhang","year":"2020","journal-title":"J Microbes Infect"},{"key":"10.1016\/j.scib.2020.12.005_b0095","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the adeasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.scib.2020.12.005_b0100","article-title":"Survivin-targeting artificial microRNAs mediated by adenovirus suppress tumor activity in cancer cells and xenograft models","volume":"3:e208","author":"Chi","year":"2014","journal-title":"Mol Ther-Nucl Acids"},{"key":"10.1016\/j.scib.2020.12.005_b0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/hep.29406","article-title":"Recombinant covalently closed circular DNA of hepatitis b virus induces long-term viral persistence with chronic hepatitis in a mouse model","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.scib.2020.12.005_b0110","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.scib.2020.12.005_b0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.scib.2020.12.005_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.115.228130","article-title":"Protoporphyrin ix: The good, the bad, and the ugly","volume":"356","author":"Sachar","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.scib.2020.12.005_b0125","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1039\/C9CS00268E","article-title":"Heme: Emergent roles of heme in signal transduction, functional regulation and as catalytic centres","volume":"48","author":"Shimizu","year":"2019","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.scib.2020.12.005_b0130","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/prot.22747","article-title":"Heme proteins\u2013diversity in structural characteristics, function, and folding","volume":"78","author":"Smith","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.scib.2020.12.005_b0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.intimp.2010.11.029","article-title":"Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy","volume":"11","author":"Ishizuka","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.scib.2020.12.005_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnci\/85.6.443","article-title":"Photodynamic therapy in oncology: mechanisms and clinical use","volume":"85","author":"Pass","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.scib.2020.12.005_b0145","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2307\/3579816","article-title":"The photobiology of photodynamic therapy: cellular targets and mechanisms","volume":"150","author":"Oleinick","year":"1998","journal-title":"Radiat Res"},{"key":"10.1016\/j.scib.2020.12.005_b0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","article-title":"Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration","volume":"45","author":"Schmidt-Erfurth","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.scib.2020.12.005_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msec.2016.09.064","article-title":"Multifunctional theranostic pluronic mixed micelles improve targeted photoactivity of verteporfin in cancer cells","volume":"71","author":"Pellosi","year":"2017","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.scib.2020.12.005_b0160","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.1074\/jbc.M110.139915","article-title":"Inhibition of autophagosome formation by the benzoporphyrin derivative verteporfin","volume":"286","author":"Donohue","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.scib.2020.12.005_b0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/00912700222011607","article-title":"Clinical pharmacokinetics of verteporfin","volume":"42","author":"Houle","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.scib.2020.12.005_b0170","unstructured":"US Food and Drug Administration Center for Drug Evaluation and Research. Application number: 208630Orig1s000. Clinical Pharmacology and Biopharmaceuticals Review(s), 2016. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2017\/208630Orig1s000ClinPharmR.pdf)"}],"container-title":["Science Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927320307283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095927320307283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:44:34Z","timestamp":1761867874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095927320307283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2095927320307283"],"URL":"https:\/\/doi.org\/10.1016\/j.scib.2020.12.005","relation":{},"ISSN":["2095-9273"],"issn-type":[{"value":"2095-9273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protoporphyrin IX and verteporfin potently inhibit SARS-CoV-2 infection in vitro and in a mouse model expressing human ACE2","name":"articletitle","label":"Article Title"},{"value":"Science Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scib.2020.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Science China Press. Published by Elsevier B.V. and Science China Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}